Drug Product
Analytical & Bioanalytical Services
Company Overview
About
Anacura is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Infectious Disease
Quick Facts
HQ:Belgium
Founded:2019
Employees:2,191
Capabilities & Services
Core Capabilities
- Small Molecule API
- Small Molecule Drug Product
- Oral Solid Dose
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Oral Solid Dose
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
Phase II
Clinical
Pilot Scale
Markets Served
Asia-Pacific
Manufacturing Facilities
1 site worldwide
Anabiotec NV
Noorwegenstraat 4, Evergem, 9940
Site Capabilities
1 capabilityANALYSIS
Regulatory Approvals
Drug Approval 10K1SL
EMA · #APR-CNJJWO9R · 2019-07-01
Drug Approval CXWVJN
FDA · #APR-G7Q7GE92 · 2022-01-01
Certifications
FDA Registration
U.S. Food and Drug Administration
Cert #: CERT-UXPQYQQ5
Issued: 2020-03-11
Expires: 2025-05-24
Health Canada GMP
Health Canada
Cert #: CERT-821G078M
Issued: 2020-07-24
Expires: 2025-12-24
Loading CDMO intelligence...
Key facts about Anacura
- Anacura is headquartered in Belgium.
- Anacura was founded in 2019.
- Anacura has 2,191 employees.
- Anacura has one manufacturing site listed on CDMO Hub, in Evergem, Belgium.
- Anacura's capabilities include Small Molecule API, Small Molecule Drug Product and Oral Solid Dose.
Find CDMOs like Anacura
Directory pages this company appears in, each with the full list of matching manufacturers.